Fennec Pharmaceuticals Inc. SEC filings FENC
Fennec Pharmaceuticals Inc. has 853 filings in SEC EDGAR's recent list, going back to Dec 10, 2002. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| S-8 | Employee stock plan registration | Jun 11, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Officer or director change
|
May 18, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2026 | Apr 27, 2026 |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 7, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Other events
|
Dec 9, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 19, 2025 | Nov 13, 2025 |
| S-8 | Employee stock plan registration | Nov 18, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 18, 2025 | Nov 17, 2025 |
| 424B5 | Prospectus supplement | Nov 18, 2025 | — |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 17, 2025 | Nov 13, 2025 |
| 424B5 | Prospectus supplement | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 3, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Other events
|
Feb 7, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 20, 2024 | Dec 18, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 30, 2024 | Oct 28, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 7, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2024 | Jun 25, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | May 13, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Other events
|
May 9, 2024 | May 7, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 21, 2024 | Mar 15, 2024 |
| 424B7 | Filing | Mar 15, 2024 | — |
| 8-K/A |
Amended current report
Results of operations
|
Mar 6, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 2, 2024 | Feb 1, 2024 |
| EFFECT | Filing | Dec 15, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Dec 6, 2023 | Dec 4, 2023 |
| UPLOAD | Letter from the SEC | Nov 28, 2023 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 6, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 7, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 4, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Other events
|
Jun 7, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Other events
|
Apr 4, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Jan 31, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2023 | Jan 25, 2023 |
| 424B3 | Prospectus | Dec 15, 2022 | — |
| EFFECT | Filing | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 8, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| S-3 | Shelf registration | Dec 1, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 17, 2022 | Oct 17, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 26, 2022 | Sep 26, 2022 |
| 8-K |
Current report
Other events
|
Sep 21, 2022 | Sep 21, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 22, 2022 | Aug 22, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 14, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Other events
|
Mar 24, 2022 | Mar 24, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 31, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Other events
|
Nov 30, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Other events
|
Nov 29, 2021 | Nov 29, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 24, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Other events
|
Jun 22, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Other events
|
May 28, 2021 | May 28, 2021 |
| DEF 14A | Proxy statement | May 25, 2021 | Jun 29, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| EFFECT | Filing | Nov 10, 2020 | — |
| CORRESP | Letter to the SEC | Nov 6, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2020 | — |
| S-3 | Shelf registration | Oct 30, 2020 | — |
| 8-K |
Current report
Material agreement
|
Oct 30, 2020 | Oct 30, 2020 |
| 424B5 | Prospectus supplement | Oct 30, 2020 | — |
| 8-K |
Current report
Other events
|
Sep 21, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Other events
|
Aug 11, 2020 | Aug 11, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 26, 2020 | Jun 25, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2020 | Jun 22, 2020 |
| 10-Q | Quarterly report | May 14, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | May 11, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
May 4, 2020 | Apr 30, 2020 |
| 424B5 | Prospectus supplement | May 1, 2020 | — |
| 424B5 | Prospectus supplement | Apr 29, 2020 | — |
| 8-K |
Current report
Other events
|
Apr 13, 2020 | Apr 13, 2020 |
| 8-K |
Current report
Other events
|
Mar 5, 2020 | Mar 5, 2020 |
| 8-K |
Current report
Other events
|
Feb 28, 2020 | Feb 28, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2020 | Feb 14, 2020 |
| 10-K | Annual report | Feb 14, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Feb 11, 2020 | Feb 11, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2019 | Sep 24, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2019 | Sep 9, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2019 | Aug 9, 2019 |
| S-8 | Employee stock plan registration | Jun 26, 2019 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2019 | Jun 18, 2019 |
| DEF 14A | Proxy statement | May 16, 2019 | Jun 18, 2019 |
| 10-Q | Quarterly report | May 10, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 9, 2019 | May 9, 2019 |
| 8-K |
Current report
Other events
|
Apr 23, 2019 | Apr 18, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2019 | Apr 15, 2019 |
| 10-K | Annual report | Mar 15, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2019 | Mar 13, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 4, 2019 | Feb 1, 2019 |
| 10-Q | Quarterly report | Nov 13, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 13, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Other events
|
Jun 11, 2018 | Jun 11, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2018 | Jun 7, 2018 |
| 10-Q | Quarterly report | May 14, 2018 | Mar 31, 2018 |
| DEF 14A | Proxy statement | May 10, 2018 | Jun 7, 2018 |
| 424B3 | Prospectus | Apr 20, 2018 | — |
| EFFECT | Filing | Apr 19, 2018 | — |
| POS AM | Filing | Apr 13, 2018 | — |
| 8-K |
Current report
Other events
|
Mar 28, 2018 | Mar 27, 2018 |
| 10-K | Annual report | Mar 28, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Other events
|
Mar 23, 2018 | Mar 21, 2018 |
| 424B5 | Prospectus supplement | Dec 11, 2017 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 11, 2017 | Dec 8, 2017 |
| FWP | Free writing prospectus | Dec 7, 2017 | — |
| 424B5 | Prospectus supplement | Dec 7, 2017 | — |
| 10-Q | Quarterly report | Nov 13, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Nov 3, 2017 | — |
| CORRESP | Letter to the SEC | Oct 31, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2017 | — |
| S-3 | Shelf registration | Oct 24, 2017 | — |
| S-8 | Employee stock plan registration | Oct 24, 2017 | — |
| 8-K |
Current report
Other events
|
Oct 16, 2017 | Oct 14, 2017 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2017 | Sep 29, 2017 |
| 424B3 | Prospectus | Sep 19, 2017 | — |
| EFFECT | Filing | Sep 18, 2017 | — |
| CORRESP | Letter to the SEC | Sep 14, 2017 | — |
| 8-K |
Current report
Other events
|
Sep 13, 2017 | Sep 13, 2017 |
| 8-A12B | Filing | Sep 11, 2017 | — |
| S-1/A | Amended registration statement | Aug 31, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2017 | — |
| CERTNAS | Auto-generated paper document | Aug 14, 2017 | — |
| 10-Q | Quarterly report | Aug 14, 2017 | Jun 30, 2017 |
| S-1 | Registration statement | Aug 10, 2017 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2017 | Jun 27, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 9, 2017 | Jun 8, 2017 |
| D | Filing | Jun 8, 2017 | — |
| DEF 14A | Proxy statement | May 24, 2017 | Jun 27, 2017 |
| 8-K |
Current report
Auditor change
|
May 17, 2017 | May 17, 2017 |
| 10-Q | Quarterly report | May 12, 2017 | Mar 31, 2017 |
| 10-K | Annual report | Mar 29, 2017 | Dec 31, 2016 |
| 8-K |
Current report
Change to shareholder rights
|
Nov 16, 2016 | Nov 16, 2016 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 12, 2016 | Jun 30, 2016 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2016 | Aug 11, 2016 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 9, 2016 | Jun 9, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 16, 2016 | May 16, 2016 |
| 10-Q | Quarterly report | May 12, 2016 | Mar 31, 2016 |
| DEF 14A | Proxy statement | May 12, 2016 | Jun 8, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 11, 2016 | Apr 8, 2016 |
| RW | Registration withdrawal request | Apr 11, 2016 | — |
| 10-K | Annual report | Mar 28, 2016 | Dec 31, 2015 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2015 | Dec 9, 2015 |
| 10-Q | Quarterly report | Nov 12, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 11, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2015 | May 28, 2015 |
| 8-K |
Current report
Material agreement
|
May 21, 2015 | May 19, 2015 |
| 10-Q | Quarterly report | May 15, 2015 | Mar 31, 2015 |
| S-1 | Registration statement | May 12, 2015 | — |
| DEF 14A | Proxy statement | May 5, 2015 | May 28, 2015 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FENC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Research Triangle Park, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1211583
- Former names
- ADHEREX TECHNOLOGIES INC (until Aug 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.